Optimizing Early-Stage Oncology: TFS’s Strategic Approach to a Dose Escalation and Expansion Phase I Trial
Discover how a U.S. biotech company partnered with a specialized CRO to manage a Phase I oncology trial for a new treatment targeting advanced epithelial tumors. The collaboration covered regulatory consulting, site identification, clinical monitoring, and other services to optimize dose escalation and expansion phases. The CRO’s expertise streamlined operations, ensuring efficiency and adherence to regulatory standards.
What You’ll Learn:
- How a specialized study team handles seamless trial execution & complex procedures effectively
- The importance of proactive site selection, including a backup site, for enrollment speed & risk reduction
- How prompt data reviews & safety updates allow for timely recruitment & study completion
- The impact of skillful management on slot allocation, patient tracking, & data cleaning
Learn more about our related services and resources:
Connect with Us
Contact us today to discover how TFS can be your strategic CRO partner in clinical development.